Total: 4 |
|
PMID (PMCID) | ||
---|---|---|
26793764 (4688829) |
OTHER | |
Delayed and clinically isolated port site carcinosarcoma recurrence as an early indicator of disseminated disease. | ||
Dandapani M, Seagle BL, Chacho MS, Shahabi S. Gynecol Oncol Rep. 2015;14:12-5. |
||
A 71-year-old woman with suspected endometrial cancer underwent robotic-assisted hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymph node dissection, and infracolic omentectomy revealing a stage II uterine carcinosarcoma with components of serous adenocarcinoma and undifferentiated spindle cell sarcoma. | ||
25197413 |
FEMALE | Middle Aged |
Synchronous uterine carcinosarcoma and contralateral breast cancer after tamoxifen therapy: a case report. | ||
Shen L, Hong L, Zhang G, Mai R. Int J Clin Exp Pathol. 2014;7(8):5295-301. |
||
Uterine carcinosarcoma (malignant mixed Mullerian tumor, MMMT) is a rare aggressive malignant tumor, which demonstrates both malignant epithelial (carcinoma) and mesenchymal (sarcoma) components. | ||
7194144 |
FEMALE | Middle Aged |
Histogenesis and culture of human uterine carcinosarcoma. | ||
Ishiwata I, Ishiwata C, Nagayama T, Ishikawa H. Cancer Res. 1981;41(5):1978-83. |
||
In in vitro cultures of human uterine carcinosarcoma, we could separate two distinct, different cell types and succeeded in establishing adenocarcinoma cell lines (HWUA-1 and HWUA-2) and sarcoma cell lines (HWUS-1, HWUS-1a, and HWUS-2). | ||
7194144 |
FEMALE | Middle Aged |
Histogenesis and culture of human uterine carcinosarcoma. | ||
Ishiwata I, Ishiwata C, Nagayama T, Ishikawa H. Cancer Res. 1981;41(5):1978-83. |
||
We set out to ascertain whether uterine carcinosarcoma represents: (a) a "collision tumor," i.e., a mixture of two histogenetically distinct malignant cell populations (endometrial carcinoma and sarcoma); (b) a "combination tumor" with both histological elements of common stem cell origin; or (c) a "composition tumor," i.e., an endometrial carcinoma with reactive, atypical stroma. |